Market News

NRXP Pharmaceuticals Surpasses Q4 2023 Earnings Expectations

by Ron Finklestien

Published On: March 28, 2024 11:31 pm

NRXP stock - NRXP Stock Earnings: NRX Pharmaceuticals Beats EPS for Q4 2023

Source: iQoncept / Shutterstock

NRXP Pharmaceuticals (NASDAQ:NRXP) recently disclosed their performance in the final quarter of 2023.

NRXP Pharmaceuticals posted earnings per share at -5 cents, exceeding the projected -7 cents by analysts.
The company refrained from revealing any revenue figures for the quarter.

InvestorPlace Earnings presents an innovative way to disburse data from TradeSmith for automated coverage of quarterly earnings reports. The project highlights key aspects like earnings per share and revenue, along with a company’s performance against analyst forecasts. These articles are generated without human intervention, enabling us to promptly update our readers on the latest financials. For any feedback or corrections, please reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/nrxp-stock-earnings-nrx-pharmaceuticals-for-q4-of-2023/.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.